Heba K Alshaeri

7PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCheminformatics and quantitative structure-activity relationshipsPreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 26, 2026
Ellagic Acid and Metformin: In Vitro Synergy and Enhanced Cisplatin Efficacy In Vivo in Resistant Breast Cancer.

|Sep 14, 2024
Natural Products and Altered Metabolism in Cancer: Therapeutic Targets and Mechanisms of Action.

Wamidh H Talib, Media Mohammad Baban, Mais Fuad Bulbul

|Sep 14, 2024
Targeting Cancer Hallmarks Using Selected Food Bioactive Compounds: Potentials for Preventive and Therapeutic Strategies.

Wamidh H Talib, Ilia Abed, Daniah Raad

|Aug 12, 2023
Design, Synthesis, and Biological Evaluation of New Potential Unusual Modified Anticancer Immunomodulators for Possible Non-Teratogenic Quinazoline-Based Thalidomide Analogs.

Reda R Mabrouk, Abdallah E Abdallah, Hazem A Mahdy

|Sep 09, 2022
Design, Synthesis, Molecular Modeling and Anti-Hyperglycemic Evaluation of Quinazoline-Sulfonylurea Hybrids as Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) and Sulfonylurea Receptor (SUR) Agonists.

Mohamed Ayman El-Zahabi, Faida H Bamanie, Salah Ghareeb

|Feb 03, 2021
Characteristics of First Cases of Coronavirus Disease 2019 and the Effort to Prevent the Early Spread of COVID-19 in Saudi Arabia.

Zuhair S Natto, Heba K Alshaeri

Pageof 2

Frequent Collaborators

3 joint publications

Wamidh H Talib

2 joint publications

Zuhair S Natto

2 joint publications

Mohamed F Zayed

1 joint publications

Reda R Mabrouk